Fresh analysis indicates that individuals who discontinue new slimming jabs like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who end traditional lifestyle programs.
Findings released in a leading health publication shows that while obese people can lose a large proportion of their body weight while on the medication, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"Users purchasing these drugs need to be aware of the danger of quick weight regain when the treatment ends," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery suggests a return to pre-treatment mass in about 18 months.
Weighing Therapies
The research, which reviewed dozens of trials involving thousands of patients, compared the results of these new drugs with conventional dieting.
Researchers point out that individuals who lose weight through diet and exercise usually experience a slower creep back—perhaps 100 grams monthly—post-intervention.
Explaining the Quick Regain
Doctors suggest the mode of action of the drugs explains the accelerated rebound.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Long-term administration of GLP-1 levels several times higher than normal could lead to the body to produce less of its own natural GLP-1, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication leads to hunger is unsuppressed, making overeating far more likely."
A Lifelong Disease?
Health authorities suggest the jabs for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.
A number of clinicians argue that, due to the likelihood of relapse, the therapy might need to be long-term.
This perspective is supported by pharmaceutical companies, who say that the results "underscore the long-term character of obesity," akin to managing conditions like diabetes.
User Accounts
People who have discontinued the jabs describe a powerful resurgence of cravings.
"It felt as if something activating and you become ravenous," said a patient.
This challenge is exacerbated if patients have not developed permanent lifestyle or habit modifications during treatment.
Significant Use
Recent estimates show that a significant number of adults in the UK have tried these injections in the past year, with demand continuing to grow.
- Adoption is greater among females than men.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, experts emphasize that while these medications are powerful agents for weight loss, they are not a standalone cure and maintained weight loss hinges on integrated behavioural changes.
